Cargando…
Arf6 as a therapeutic target: Structure, mechanism, and inhibitors
ADP-ribosylation factor 6 (Arf6), a small G-protein of the Ras superfamily, plays pivotal roles in multiple cellular events, including exocytosis, endocytosis, actin remodeling, plasma membrane reorganization and vesicular transport. Arf6 regulates the progression of cancer through the activation of...
Autores principales: | Sun, Dejuan, Guo, Yuanyuan, Tang, Piyu, Li, Hua, Chen, Lixia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547916/ https://www.ncbi.nlm.nih.gov/pubmed/37799386 http://dx.doi.org/10.1016/j.apsb.2023.06.008 |
Ejemplares similares
-
The regulatory mechanisms and inhibitors of isocitrate dehydrogenase 1 in cancer
por: Liu, Yang, et al.
Publicado: (2023) -
Long non-coding RNAs as potential therapeutic targets in non-small cell lung cancer (Review)
por: Tang, Peiyu, et al.
Publicado: (2023) -
ARF-BP1 as a potential therapeutic target
por: Chen, D, et al.
Publicado: (2006) -
Chlortetracycline, a Novel Arf Inhibitor That Decreases the Arf6-Dependent Invasive Properties of Breast Cancer Cells
por: Macia, Eric, et al.
Publicado: (2021) -
Targeting EGFR-dependent tumors by disrupting an ARF6-mediated sorting system
por: Guo, Huiling, et al.
Publicado: (2022)